logo
logo
Sign in

Fiducial Markers Market Size, Key Market Players, SWOT, Revenue Growth Analysis, 2020–2027

avatar
jhon tanison

Rising occurrence of cancer is one of the significant factors influencing the market growth.

Market Size – USD 90.6 Million in 2019, Market Growth - CAGR of 4.3%, Market Trends – Increasing investment in cancer research

The global fiducial markers market is expected to reach USD 127.3 Million by 2027, according to a new report by Reports and Data. Fiducial markers find usage in image-guided radiotherapy procedures, where the placement of the markers is by modalities such as computed tomography (CT) or ultrasound, among others, and may encompass the application of an endoscope. Fiducial markers assist in precisely locating a tumor, thereby allowing the radiologist or a team of radiologists to provide the maximum radiation dosage to the tumor while mitigating the dose radiation imparted to healthy tissue in the vicinity.

The growing prevalence of cancer is a significant factor in driving the fiducial markers market growth. Cancer has a significant impact on global society, including the US. Detection of the disease at an early stage significantly increases the chances of survival. Creating awareness to encourage early diagnosis and screening are the crucial steps responsible for early detection of the disease. Identifying likely warning symptoms of the disease and taking rapid measures is necessary for early diagnosis. Greater awareness of probable symptoms of cancer amongst physicians, nurses, and other healthcare providers, in addition to the general public, would positively impact the survival rate and hence would be instrumental in increasing the market demand. The American Cancer Society proposes that in 2020, over 1.8 million individuals are likely to be diagnosed with cancer, of which various patients would require a blood transfusion, occasionally on a daily basis.

 

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3471

 

The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.

 

Key companies operating in the market and profiled in the report include:

Boston Scientific Corporation, Naslund Medical AB, Carbon Medical Technologies, Stellar Medical, CIVCO Radiotherapy, Medtronic, Innovative Oncology Solutions, IZI Medical Products, Nanovi A/S, and Eckert & Ziegler, among others.

 

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3471

 

The Fiducial Markers market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.

 

Segments Covered in the report

Type Outlook (Revenue, USD Million; 2017-2027)

  • Metal-Based Markers
  • Polymer-Based Markers
  • Others

Modalities Outlook (Revenue, USD Million; 2017-2027)

  • Computed Tomography/Computer-Based Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Radiotherapy

Application Outlook (Revenue, USD Million; 2017-2027)

  • Prostate cancer
  • Lung Cancer
  • Breast Cancer
  • Gastric Cancer
  • Others

End-User Outlook (Revenue, USD Million; 2017-2027)

  • Hospitals
  • Radiotherapy Centers
  • Academic & Research Centers

 

Key Regions Analyzed in the Report include:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

 

To know more about the report @ https://www.reportsanddata.com/report-detail/fiducial-markers-market

 

Furthermore, it consists information about individual segment of the Fiducial Markers market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.

 

Further key findings from the report suggest

  • By type, metal-based markers contributed to the largest fiducial markers market size in 2019. Metal-based markers such as gold fiducial markers find widespread application owing to the offering of benefits like a high contrast level and better visualization.
  • By modalities, ultrasound is likely to grow at a rate of 4.7% in the forecast period for the fiducial markers market, attributed to a lower level of toxicity associated with ionizing radiation, as well as cost-effectiveness as compared to other forms of modalities.
  • By cancer type, lung cancer is likely to witness a growth rate of 4.8% in the forecast period for the fiducial markers market. It may occur due to various reasons, including smoking, genetic, and exposure to toxic gases. The American Cancer Society projects over 228,000 lung cancer cases, with the occurrence of the disease being higher in men than women. It is a significant cause of death in both US men and women dying due to cancer.
  • The fiducial markers market in the Asia Pacific region is expected to grow at the fastest rate of 5.5% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities the diagnostic procedures, among others.

 

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3471

 

Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.

Browse More Reports:

mRNA Cancer Vaccines And Therapeutics Market

Peptide Cancer Vaccine Market

 

 

 

 

 

collect
0
avatar
jhon tanison
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more